Literature DB >> 15886173

Medicaid cost containment and access to prescription drugs.

Peter J Cunningham1.   

Abstract

States have been intensifying their efforts to control rising prescription drug costs in their Medicaid programs. This study examines the effects of five Medicaid cost containment policies on enrollees' perceptions of their ability to get prescription drugs. The results show that enrollees in states that have implemented all or almost all of these five policies have greater problems getting prescription drugs than enrollees in other states encounter. In terms of specific policies, prior authorization and mandatory generic substitutions had the largest effects on access to prescription drugs.

Mesh:

Year:  2005        PMID: 15886173     DOI: 10.1377/hlthaff.24.3.780

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  18 in total

1.  State Investments in Psychiatric Innovation: Investigating Unmeasured State Factors.

Authors:  Marisa Elena Domino; Christopher Alan Beadles
Journal:  Health Serv Outcomes Res Methodol       Date:  2014-06-01

Review 2.  Defining interdisciplinary research: conclusions from a critical review of the literature.

Authors:  Sally W Aboelela; Elaine Larson; Suzanne Bakken; Olveen Carrasquillo; Allan Formicola; Sherry A Glied; Janet Haas; Kristine M Gebbie
Journal:  Health Serv Res       Date:  2007-02       Impact factor: 3.402

Review 3.  Impact of pharmaceutical prior authorisation policies : a systematic review of the literature.

Authors:  Jaume Puig-Junoy; Iván Moreno-Torres
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.

Authors:  Seung Jin Bae; A David Paltiel; Anne L Fuhlbrigge; Scott T Weiss; Karen M Kuntz
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

5.  Medicaid prescription formulary restrictions and arthritis treatment costs.

Authors:  Tricia J Johnson; Stephanie Stahl-Moncada
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

6.  Factors Associated with Geographic Variation in Psychiatric Prescription Drug Expenditures Among Medicaid Beneficiaries.

Authors:  Julia Zur; Leighton Ku
Journal:  J Behav Health Serv Res       Date:  2016-07       Impact factor: 1.505

7.  Providing a framework for assessment of the access to medicine.

Authors:  Monireh Afzali; Elahe Khorasani; Mahdi Alvandi; Mansoureh Sabbagh-Bani-Azad; Zahra Sharif; Parisa Saiyarsarai; Shekoufeh Nikfar
Journal:  Daru       Date:  2019-05-04       Impact factor: 3.117

8.  Improving psychotherapeutic medication prescribing in Florida: implementation of the Florida Medicaid Drug Therapy Management Program (MDTMP).

Authors:  Robert J Constantine; Marie A McPherson; Mary Elizabeth Jones; Rajiv Tandon; Edmund R Becker
Journal:  Community Ment Health J       Date:  2012-03-01

9.  The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.

Authors:  Bradley D Stein; Emily Leckman-Westin; Edward Okeke; Deborah M Scharf; Mark Sorbero; Qingxian Chen; Ka Ho Brian Chor; Molly Finnerty; Jennifer P Wisdom
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-08-21       Impact factor: 2.576

Review 10.  Review of Current Policy Strategies to Reduce US Cancer Drug Costs.

Authors:  Angela K Green; Jennifer A Ohn; Peter B Bach
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.